Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kohjin Bio CoTSE:177A -1.11%17 Return-on-Tangible-Equity is 1.67% as of Mar. 2026, which is 90% below its 10-year median of 17.48. GuruFocus rates TSE:177A with a GF Score™ of 17/100. The stock has 3 warning signs investors should review. Among 1,200 Biotechnology companies, Kohjin Bio Co ranks better than 80.75% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Kohjin Bio Co's annualized net income for the quarter that ended in Mar. 2026 was 円98 Mil. Kohjin Bio Co's average shareholder tangible equity for the quarter that ended in Mar. 2026 was 円5,859 Mil. Therefore, Kohjin Bio Co's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 1.67%.
The historical rank and industry rank for Kohjin Bio Co's Return-on-Tangible-Equity or its related term are showing as below:
TSE:177A'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 4.3 Med: 17.48 Max: 31.77
Current: 4.31
During the past 5 years, Kohjin Bio Co's highest Return-on-Tangible-Equity was 31.77%. The lowest was 4.30%. And the median was 17.48%.
TSE:177A's Return-on-Tangible-Equity is ranked better than 80.75% of 1200
companies
in the Biotechnology industry
Industry Median: -42.305
vs TSE:177A: 4.31
Kohjin Bio Co (TSE:177A) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Kohjin Bio Co Return-on-Tangible-Equity Related Terms
Kohjin Bio Co Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Kohjin Bio Co's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:177A vs VRTX, REGN, ALNY: Return-on-Tangible-Equity Comparison
For the Biotechnology subindustry, Kohjin Bio Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kohjin Bio Co Return-on-Tangible-Equity vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kohjin Bio Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Kohjin Bio Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 1.67% mean?
Kohjin Bio Co (TSE:177A) has a Return-on-Tangible-Equity of 1.67% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Kohjin Bio Co and its competitors. This is 90% below median its historical median of 17.48. Over the past decade, Kohjin Bio Co's Return-on-Tangible-Equity has ranged from 4.30 to 31.77. According to the industry distribution chart, Kohjin Bio Co ranks #231 out of 1200 companies in the Biotechnology industry, placing it in the top 19.2%.
Is Kohjin Bio Co's Return-on-Tangible-Equity too high?
Kohjin Bio Co's current Return-on-Tangible-Equity of 1.67% is 90% below median its 10-year median of 17.48. Over the past 10 years, this metric has ranged from a low of 4.30 to a high of 31.77. Based on the distribution chart, Kohjin Bio Co ranks #231 out of 1200 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Kohjin Bio Co has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Kohjin Bio Co's Return-on-Tangible-Equity compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kohjin Bio Co ranks #231 out of 1200 companies for Return-on-Tangible-Equity. This places Kohjin Bio Co in the top 19% of its industry — outperforming the majority of peers. Historically, Kohjin Bio Co's own Return-on-Tangible-Equity has ranged from 4.30 to 31.77 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Biotechnology company?
A good Return-on-Tangible-Equity depends on the Biotechnology industry context. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Kohjin Bio Co and its competitors. Kohjin Bio Co's current Return-on-Tangible-Equity is 1.67%, which is 90% below median its own 10-year median of 17.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kohjin Bio Co stock overvalued right now?
Kohjin Bio Co (TSE:177A) has a current Return-on-Tangible-Equity of 1.67%. The current Return-on-Tangible-Equity is 1.67%, which is 90% below median its 10-year median of 17.48. Kohjin Bio Co's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Kohjin Bio Co (TSE:177A), the current Return-on-Tangible-Equity is 1.67% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kohjin Bio Co Ltd is engaged in development, manufacture and sale of culture media (growing environments used for culturing microorganisms and cells) and contract manufacturing of processed cell products. It has manufacturing and sales of animal blood, sera, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics.
17GF Score
Get the complete analysis for TSE:177A
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:177A has been successfully added to your 
